Related Experiment Video
Updated: Mar 28, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Vascular calcification, bone and mineral metabolism after kidney transplantation
Luis D'Marco1, Antonio Bellasi1, Sandro Mazzaferro1
1Luis D'Marco, Unidad Avanzada de Investigación y Diagnostico Ecográfico y Renal, Clínica Puerto Ordaz, Puerto Ordaz 8050, Venezuela.
Insights
End-stage renal failure patients face high cardiovascular disease risk. Kidney transplants improve outcomes but don't fully resolve cardiovascular risks or mineral imbalances, impacting long-term health.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Bone Disease
Background:
- End-stage renal failure (ESRF) patients have the highest cardiovascular disease (CVD) risk.
- Kidney transplantation is optimal but immune-suppressive drugs and unresolved mineral/bone metabolism issues persist.
- Cardiovascular risk factors remain prevalent post-transplantation.
Purpose of the Study:
- To review the impact of chronic kidney disease (CKD) on cardiovascular health in post-transplant patients.
- To examine the role of mineral and bone metabolism alterations in CKD progression and cardiovascular outcomes.
- To assess the contribution of vascular calcification to poor cardiovascular outcomes in kidney transplant recipients.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of cardiovascular risk factors in ESRF and post-transplant populations.
- Examination of mineral and bone metabolism pathways and their link to vascular calcification.
Main Results:
- Cardiovascular disease remains a significant challenge post-kidney transplantation.
- Immune-suppressive therapies can exacerbate cardiovascular risk profiles.
- Altered mineral and bone metabolism in ESRF may promote vascular calcification, a hallmark of CKD.
Conclusions:
- Vascular calcification is a key concern in CKD progression and post-transplant cardiovascular outcomes.
- Further research is needed to mitigate cardiovascular risks associated with CKD and transplantation.
- Addressing mineral and bone metabolism is crucial for improving cardiovascular health in kidney failure patients.
Abstract:
The development of end stage renal failure can be seen as a catastrophic health event and patients with this condition are considered at the highest risk of cardiovascular disease among any other patient groups and risk categories. Although kidney transplantation was hailed as an optimal solution to such devastating disease, many issues related to immune-suppressive drugs soon emerged and it became evident that cardiovascular disease would remain a vexing problem. Progression of chronic kidney disease is accompanied by profound alterations of mineral and bone metabolism that are believed to have an impact on the cardiovascular health of patients with advanced degrees of renal failure. Cardiovascular risk factors remain highly prevalent after kidney transplantation, some immune-suppression drugs worsen the risk profile of graft recipients and the alterations of mineral and bone metabolism seen in end stage renal failure are not completely resolved. Whether this complex situation promotes progression of vascular calcification, a hall-mark of advanced chronic kidney disease, and whether vascular calcifications contribute to the poor cardiovascular outcome of post-transplant patients is reviewed in this article.
Related Concept Videos
Skeleton and Calcium Homeostasis
Kidney Transplant III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi IV: Nutrition Therapy and Prevention

